Predictors for initiation of pharmacological prophylaxis in patients with newly diagnosed bipolar disorder - A nationwide cohort study

Journal of Affective Disorders

Volumn 172, Issue , 2015, Pages 204-210

  Scheen, Louise ^a   Brandt, Lena ^a   Bodén, Robert ^a,b   Tiihonen, Jari ^a,c   Andersen, Morten ^a   Kieler, Helle ^a   Reutfors, Johan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Bipolar disorder; Cohort study; Medication adherence; Pharmacoepidemiology

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; VALPROIC ACID;

ADULT; AGED; ARTICLE; AUTOMUTILATION; BIPOLAR DISORDER; COHORT ANALYSIS; DISEASE REGISTRY; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MENTAL HEALTH CARE; OUTCOME ASSESSMENT; OUTPATIENT; OUTPATIENT CARE; PATIENT COMPLIANCE; PERSONALITY; PHARMACEUTICAL CARE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PROPHYLAXIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUICIDE ATTEMPT; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; SWEDEN; YOUNG ADULT;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; COHORT STUDIES; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SWEDEN; YOUNG ADULT;

EID: 84908377250     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.09.044     Document Type: Article

References (40)

1. J. Aagaard, and P. Vestergaard Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study J. Affect. Disord. 18 1990 259 266
2. J. Aagaard, P. Vestergaard, and K. Maarbjerg Adherence to lithium prophylaxis: II. Multivariate analysis of clinical, social, and psychosocial predictors of nonadherence Pharmacopsychiatry 21 1988 166 170
3. P. Arvilommi, K. Suominen, O. Mantere, S. Leppamaki, H. Valtonen, and E. Isometsa Predictors of adherence to psychopharmacological and psychosocial treatment in bipolar I or II disorders - an 18-month prospective study J. Affect. Disord. 155 2014 110 117
4. American Psychiatric Association (APA): Practice guideline for the treatment of patients with bipolar disorder (revision), Am. J. Psychiatry. 159, 2002, 1-50
5. R. Baldessarini, H. Henk, A. Sklar, J. Chang, and L. Leahy Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence Psychiatr. Serv. 59 2008 1175 1183
6. R.J. Baldessarini, R. Perry, and J. Pike Factors associated with treatment nonadherence among US bipolar disorder patients Hum. Psychopharmacol. 23 2008 95 105
7. R.J. Baldessarini, L. Tondo, C.J. Baethge, B. Lepri, and I.M. Bratti Effects of treatment latency on response to maintenance treatment in manic-depressive disorders Bipolar Disord. 9 2007 386 393
8. M. Berk, A. Brnabic, S. Dodd, K. Kelin, M. Tohen, G.S. Malhi, L. Berk, P. Conus, and P.D. McGorry Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention Bipolar Disord. 13 2011 87 98
9. R. Boden, L. Brandt, H. Kieler, M. Andersen, and J. Reutfors Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder Schizophr. Res. 133 2011 36 41
10. J.R. Calabrese, R.M. Hirschfeld, M. Reed, M.A. Davies, M.A. Frye, P.E. Keck, L. Lewis, S.L. McElroy, J.P. McNulty, and K.D. Wagner Impact of bipolar disorder on a U.S. community sample J. Clin. Psychiatry 64 2003 425 432
11. F. Colom, E. Vieta, A. Martinez-Aran, M. Reinares, A. Benabarre, and C. Gasto Clinical factors associated with treatment noncompliance in euthymic bipolar patients J. Clin. Psychiatry 61 2000 549 555
12. C. Crump, K. Sundquist, M.A. Winkleby, and J. Sundquist Comorbidities and mortality in bipolar disorder: a Swedish national cohort study JAMA Psychiatry 70 2013 931 939
13. M.P. DelBello, D. Hanseman, C.M. Adler, D.E. Fleck, and S.M. Strakowski Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode Am. J. Psychiatry 164 2007 582 590
14. R.A. Desai, D.J. Dausey, and R.A. Rosenheck Mental health service delivery and suicide risk: the role of individual patient and facility factors Am. J. Psychiatry 162 2005 311 318
15. N. Divac, N.P. Maric, A. Damjanovic, A.A. Jovanovic, M. Jasovic-Gasic, and M. Prostran Use or underuse of therapeutic guidelines in psychiatry? Psychiatr. Danub. 21 2009 224 229
16. J.R. Geddes, S. Burgess, K. Hawton, K. Jamison, and G.M. Goodwin Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials Am. J. Psychiatry 161 2004 217 222
17. S.N. Ghaemi, E.E. Boiman, and F.K. Goodwin Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study J. Clin. Psychiatry 61 2000 804 808 (quiz 809)
18. J.F. Goldberg, and C.L. Ernst Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder J. Clin. Psychiatry 63 2002 985 991
19. J.F. Goldberg, and C.J. Truman Antidepressant-induced mania: an overview of current controversies Bipolar Disord. 5 2003 407 420
20. A. Gonzalez-Pinto, C. Reed, D. Novick, J. Bertsch, and J.M. Haro Assessment of medication adherence in a cohort of patients with bipolar disorder Pharmacopsychiatry 43 2010 263 270
21. H. Jonsdottir, S. Opjordsmoen, A.B. Birkenaes, C. Simonsen, J.A. Engh, P.A. Ringen, A. Vaskinn, S. Friis, K. Sundet, and O.A. Andreassen Predictors of medication adherence in patients with schizophrenia and bipolar disorder Acta Psychiatr. Scand. 127 2013 23 33
22. P.E. Keck Jr., S.L. McElroy, S.M. Strakowski, M.L. Bourne, and S.A. West Compliance with maintenance treatment in bipolar disorder Psychopharmacol. Bull. 33 1997 87 91
23. L.V. Kessing Diagnostic stability in bipolar disorder in clinical practise as according to ICD-10 J. Affect. Disord. 85 2005 293 299
24. L.V. Kessing, G. Hellmund, and P.K. Andersen Predictors of excellent response to lithium: results from a nationwide register-based study Int. Clin. Psychopharmacol. 26 2011 323 328
25. L.V. Kessing, L. Sondergard, K. Kvist, and P.K. Andersen Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study Bipolar Disord. 9 2007 730 736
26. T.A. Ketter, J.P. Houston, D.H. Adams, R.C. Risser, A.L. Meyers, D.J. Williamson, and M. Tohen Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes J. Clin. Psychiatry 67 2006 95 101
27. J.F. Ludvigsson, E. Andersson, A. Ekbom, M. Feychting, J.L. Kim, C. Reuterwall, M. Heurgren, and P.O. Olausson External review and validation of the Swedish national inpatient register BMC Public Health 11 2011 450
28. P.L. Morselli, and R. Elgie GAMIAN-Europe/BEAM survey I - global analysis of a patient questionnaire circulated to 3450 members of 12 European advocacy groups operating in the field of mood disorders Bipolar Disord. 5 2003 265 278
29. B. Muller-Oerlinghausen, A. Berghofer, and M. Bauer Bipolar disorder Lancet 359 2002 241 247
30. F. Nery-Fernandes, L.C. Quarantini, J.L. Guimaraes, I.R. de Oliveira, K.C. Koenen, F. Kapczinski, and A. Miranda-Scippa Is there an association between suicide attempt and delay of initiation of mood stabilizers in bipolar I disorder? J. Affect. Disord. 136 2012 1082 1087
31. R.H. Perlis, M.J. Ostacher, D.J. Miklowitz, A. Hay, A.A. Nierenberg, M.E. Thase, and G.S. Sachs Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study J. Clin. Psychiatry 71 2010 296 303
32. J. Reutfors, L. Brandt, O. Stephansson, H. Kieler, M. Andersen, and R. Boden Antipsychotic prescription filling in patients with schizophrenia or schizoaffective disorder J. Clin. Psychopharmacol. 33 2013 759 765
33. M. Sajatovic, M. Valenstein, F. Blow, D. Ganoczy, and R. Ignacio Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder Psychiatr. Serv. 58 2007 855 863
34. L. Samalin, S. Guillaume, C. Auclair, and P.M. Llorca Adherence to guidelines by French psychiatrists in their real world of clinical practice J. Nerv. Ment. Dis. 199 2011 239 243
35. S.M. Strakowski, P.E. Keck Jr., S.L. McElroy, S.A. West, K.W. Sax, J.M. Hawkins, G.F. Kmetz, V.H. Upadhyaya, K.C. Tugrul, and M.L. Bourne Twelve-month outcome after a first hospitalization for affective psychosis Arch. Gen. Psychiatry 55 1998 49 55
36. T. Suppes, G.S. Leverich, P.E. Keck, W.A. Nolen, K.D. Denicoff, L.L. Altshuler, S.L. McElroy, A.J. Rush, R. Kupka, M.A. Frye, M. Bickel, and R.M. Post The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients J. Affect. Disord. 67 2001 45 59
37. M. Tohen, C.A. Zarate Jr., J. Hennen, H.M. Khalsa, S.M. Strakowski, P. Gebre-Medhin, P. Salvatore, and R.J. Baldessarini The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence Am. J. Psychiatry 160 2003 2099 2107
38. The Swedish National Board of Health and Welfare: National guidelines for care in cases of depression and anxiety disorders, 2010, Retrieved from http://www.socialstyrelsen.se/nationalguidelines, Accessed on May 26, 2014.
39. D.I. Velligan, P.J. Weiden, M. Sajatovic, J. Scott, D. Carpenter, R. Ross, and J.P. Docherty Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines J. Psychiatr. Pract. 16 2010 306 324
40. B. Wettermark, N. Hammar, C.M. Fored, A. Leimanis, P. Otterblad Olausson, U. Bergman, I. Persson, A. Sundstrom, B. Westerholm, and M. Rosen The new Swedish Prescribed Drug Register - opportunities for pharmacoepidemiological research and experience from the first six months Pharmacoepidemiol. Drug Saf. 16 2007 726 735